Mevalonate Kinase Deficiency
Publication date
2019-01-01
Editors
Advisors
Supervisors
Document Type
Part of book
Metadata
Show full item recordCollections
License
taverne
Abstract
Mevalonate kinase deficiency (MKD) is a rare autoinflammatory disease caused by loss of function mutations in both alleles of MVK, the gene encoding the enzyme mevalonate kinase. Deficiency of this enzyme results in impaired isoprenoid biosynthesis. The inflammatory attacks in MKD are characterized by fever, lymphadenopathy, gastrointestinal symptoms, aphthous ulcers, rash, arthralgias and/or arthritis. Severely affected patients may in addition have neurological involvement, cataract, uveitis, and failure to thrive, often dying in early childhood. This severe end of the phenotypic spectrum is called mevalonic aciduria (MA) as opposed to the milder phenotype also known as hyperimmunoglobulinemia D periodic fever syndrome (HIDS). In this chapter, we detail clinical phenotype and pathophysiological background as well as treatment options.
Keywords
Autoinflammatory, Hyperimmunoglobulinemia D syndrome, Isoprenoid metabolism, Mevalonate kinase deficiency, Mevalonic aciduria, Periodic fever, Taverne, General Medicine, General Immunology and Microbiology
Citation
Frenkel, J & Simon, A 2019, Mevalonate Kinase Deficiency. in Textbook of Autoinflammation. Springer, pp. 315-327. https://doi.org/10.1007/978-3-319-98605-0_17